Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: bdusa1 who wrote (1138)	12/19/1997 8:09:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 7041

<<in due time we will know>> Correction. We already know. We know that phentolamine mesylate is an ancient generic drug which is ineffective for the treatment of ED. We know that Zonagen has taken advantage of the mini-mania in male impotency drugs to hype the stock by issuing false research reports through paid shills. We know that the company has a long track record of atrocious performance. We know the company has knowingly misled investors. We know that the stock still trades at a ridiculous valuation.